1.Effective evaluation of Mizoribine in the early period after renal transplantation
Liuyong ZHANG ; Xiangfei YAO ; Qing XUE ; Yuhui FAN
Chinese Journal of Tissue Engineering Research 2007;0(16):-
0.05).②blood test and gastrointestinal reaction of the two groups one month after operation:The leukocytopenia(
2.Risk factors and predictive effectiveness of PI-RADS after targeted combined system puncture for CsPCa patients with 3 points
Weiqiang HU ; Weimin GAN ; Xiaoqun YAO ; Jianguang HE ; Ning DING ; Kunlong LIU ; Liuyong ZHANG ; Junping WANG ; Hui LIU
Journal of Modern Urology 2023;28(8):692-695
【Objective】 To investigate the risk factors and predictive effectiveness of prostate imaging reporting and data system (PI-RADS) score for patients with clinically significant prostate cancer (CsPCa) whose PI-RADS score was 3, so as to provide evidence for the diagnosis and treatment. 【Methods】 The clinical and multi-parameter magnetic resonance imaging (mpMRI) data of 153 CsPCa patients treated during Jan.2017 and Dec.2021 whose PI-RADS score was 3 were retrospectively analyzed. With PI-RADS score of 3 as the independent risk factor for CsPCa, the other relevant independent risk factors in predicting CsPCa were evaluated. 【Results】 Univariate and multivariate analyses showed that prostate-specific antigen (PSA) density and apparent dispersion coefficient (ADC) were independent risk factors for the diagnosis of CsPCa (P<0.05). Analysis of receiver operating characteristic (ROC) curve showed that combined PSA density and ADC were more effective than PSA density and ADC alone (P<0.05). 【Conclusion】 The combination of PSA density and ADC can guide clinicians to identify high-risk CsPCa patients from patients with PI-RADS score of 3 points.